Lupin Limited has informed the Exchange regarding a press release dated September 06, 2021, titled "TB Alliance and Lupin Announce Commercial Partnership for New Therapy for Highly Drug-Resistant TB.".
Lupin Limited has informed the Exchange regarding a press release dated September 06, 2021, titled "TB Alliance and Lupin Announce Commercial Partnership for New Therapy for Highly Drug-Resistant TB.".